Seer (SEER) Other Accumulated Expenses (2022 - 2026)

Seer (SEER) posted quarterly Other Accumulated Expenses of $38000.0 for Q1 2026, down 7.32% year-over-year from $41000.0 in Q1 2025, and up 31.03% quarter-over-quarter from $29000.0 in Q4 2025.

Seer (SEER) Other Accumulated Expenses (2022 - 2026) Analysis & Trends

Seer's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $38000.0 for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses fell 7.32% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $38000.0 (down 7.32% YoY), while the FY2025 annual figure was $29000.0, down 42.0% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $38000.0, up from $29000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $207000.0 in Q4 2022, with the low at $18000.0 in Q3 2025.
  • The 5-year median for Other Accumulated Expenses is $131000.0 (2023), against an average of $110812.5.
  • The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses climbed 17.89% in 2024, then slumped 87.59% in 2025.
  • Seer's Other Accumulated Expenses stood at $207000.0 in 2022, then tumbled by 32.85% to $139000.0 in 2023, then plunged by 64.03% to $50000.0 in 2024, then sank by 42.0% to $29000.0 in 2025, then jumped by 31.03% to $38000.0 in 2026.
  • Business Quant data shows SEER's Other Accumulated Expenses at $38000.0 in Q1 2026, $29000.0 in Q4 2025, and $18000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Seer 230.63 Mn 230.63 Mn 1.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 22,000.00
Mar 31, 2026 38,000.00
Dec 31, 2025 29,000.00
Sep 30, 2025 18,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 41,000.00
Dec 31, 2024 50,000.00
Sep 30, 2024 145,000.00
Jun 30, 2024 140,000.00
Mar 31, 2024 145,000.00
Dec 31, 2023 139,000.00
Sep 30, 2023 123,000.00
Jun 30, 2023 122,000.00
Mar 31, 2023 172,000.00
Dec 31, 2022 207,000.00
Sep 30, 2022 181,000.00
Jun 30, 2022 197,000.00